BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31092466)

  • 21. Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Ann Thorac Surg; 2017 Jul; 104(1):313-320. PubMed ID: 28433219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of part-solid lung cancer in the eighth edition TNM staging system.
    Okamoto T; Miyawaki M; Toyokawa G; Karashima T; Abe M; Takumi Y; Hashimoto T; Osoegawa A; Tagawa T; Takeuchi H; Shimokawa M; Sugio K
    Interact Cardiovasc Thorac Surg; 2022 Jan; 34(2):219-226. PubMed ID: 34561707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
    Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: prognostic comparison using high-resolution computed tomography findings.
    Tsutani Y; Miyata Y; Yamanaka T; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):17-23. PubMed ID: 23246051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of High-Grade Patterns in Early-Stage Lung Adenocarcinoma: A Multicentric Analysis.
    Bertoglio P; Aprile V; Ventura L; Cattoni M; Nachira D; Lococo F; Perez MR; Guerrera F; Minervini F; Querzoli G; Bocchialini G; Bacchin D; Franzi F; Rindi G; Bellafiore S; Femia F; Bogina GS; Solli P; Kestenholz P; Ruffini E; Paci M; Margaritora S; Imperatori AS; Lucchi M; Gnetti L; Terzi AC
    Lung; 2022 Oct; 200(5):649-660. PubMed ID: 35988096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should resection extent be decided by total lesion size or solid component size in ground glass opacity-containing lung adenocarcinomas?
    Lin B; Wang R; Chen L; Gu Z; Ji C; Fang W
    Transl Lung Cancer Res; 2021 Jun; 10(6):2487-2499. PubMed ID: 34295656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer.
    Inoue M; Minami M; Sawabata N; Utsumi T; Kadota Y; Shigemura N; Okumura M
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1445-9. PubMed ID: 20137967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of tumor size eliminating the ground glass opacity component: modified clinical T descriptors of the tumor, node, metastasis classification of lung cancer.
    Nakamura S; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ishiguro F; Hirakawa A; Yokoi K
    J Thorac Oncol; 2013 Dec; 8(12):1551-7. PubMed ID: 24389437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non-Small Cell Lung Cancer.
    Aokage K; Miyoshi T; Ishii G; Kusumoto M; Nomura S; Katsumata S; Sekihara K; Tane K; Tsuboi M
    J Thorac Oncol; 2018 Apr; 13(4):533-542. PubMed ID: 29246833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid Lung Cancer.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Ann Thorac Surg; 2016 Aug; 102(2):407-15. PubMed ID: 27177840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma.
    Uehara H; Tsutani Y; Okumura S; Nakayama H; Adachi S; Yoshimura M; Miyata Y; Okada M
    Ann Thorac Surg; 2013 Dec; 96(6):1958-65. PubMed ID: 24021765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The more the micropapillary pattern in stage I lung adenocarcinoma, the worse the prognosis-a retrospective study on digitalized slides.
    Zombori T; Nyári T; Tiszlavicz L; Pálföldi R; Csada E; Géczi T; Ottlakán A; Pécsy B; Cserni G; Furák J
    Virchows Arch; 2018 Jun; 472(6):949-958. PubMed ID: 29611055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
    Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
    Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage IA non-small-cell lung cancer in the eighth edition TNM classification.
    Jiang T; Li M; Lin M; Zhao M; Zhan C; Feng M
    Cancer Manag Res; 2019; 11():2951-2961. PubMed ID: 31114343
    [No Abstract]   [Full Text] [Related]  

  • 37. Correlation between whole tumor size and solid component size on high-resolution computed tomography in the prediction of the degree of pathologic malignancy and the prognostic outcome in primary lung adenocarcinoma.
    Saji H; Matsubayashi J; Akata S; Shimada Y; Kato Y; Kudo Y; Nagao T; Park J; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Acta Radiol; 2015 Oct; 56(10):1187-95. PubMed ID: 25344503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do ground-glass opacity-dominant features have prognostic significance in node-negative adenocarcinomas with invasive components of similar sizes?
    Han SJ; Jeon JH; Jung W; Seong YW; Cho S; Kim K; Jheon S
    Eur J Cardiothorac Surg; 2020 Jun; 57(6):1189-1194. PubMed ID: 32047887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma.
    Ye B; Cheng M; Li W; Ge XX; Geng JF; Feng J; Yang Y; Hu DZ
    Ann Thorac Surg; 2014 Jul; 98(1):217-23. PubMed ID: 24841547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiological classification of multiple lung cancers and the prognostic impact based on the presence of a ground glass opacity component on thin-section computed tomography.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Lung Cancer; 2017 Nov; 113():7-13. PubMed ID: 29110852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.